在宅検査キット市場：検査形式別（ストリップ、スティック、カセット、その他）、分析対象流体別（尿、血液、便）、治療領域別（不妊と生殖の健康、代謝性疾患、感染症、腫瘍性疾患）、主要地域別（北米（米国、北米（米国、カナダ、その他の北米地域）、欧州（英国、ドイツ、フランス、イタリア、スペイン、その他の欧州地域）、アジア太平洋地域（インド、中国、日本、韓国、インドネシア、その他のアジア太平洋地域）、アフリカ（ナイジェリア、エチオピア、エジプト、その他のアフリカ地域）、南米（アルゼンチン、ブラジル、その他の南米地域））：産業動向と世界予測、2022-2035年

At Home Testing Kits Market, Distribution by Type of Test Format (Strip, Stick, Cassette, and Others), Type of Biofluid Analyzed (Urine, Blood, and Stool), Therapeutic Area (Fertility and Reproductive Health, Metabolic Disorders, Infectious Diseases and Oncological Disorders) and Key Geographical Regions (North America (US, Canada and Rest of North America), Europe (UK, Germany, France, Italy, Spain and Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, Indonesia and Rest of Asia-Pacific), Africa (Nigeria, Ethiopia, Egypt and Rest of Africa) and South America (Argentina, Brazil and Rest of South America)): Industry Trends and Global Forecasts, 2022-2035

在宅検査市場は2022年に148億米ドルに達すると推定され、予測期間2022-2035年の年平均成長率は6％と予測されている。 1976年の初期に最初の市販検査キットが登場して以来、このような製品の開発を目指した取り... もっと見る

出版社	出版年月	電子版価格	ページ数	言語
Roots Analysis ルーツアナリシス	2023年9月1日	US$4,799 シングルユーザライセンスライセンス・価格情報注文方法はこちら	496	英語

サマリー

在宅検査市場は2022年に148億米ドルに達すると推定され、予測期間2022-2035年の年平均成長率は6％と予測されている。

1976年の初期に最初の市販検査キットが登場して以来、このような製品の開発を目指した取り組みが顕著に急増している。市場の活力を示す重要な指標は、米国で年間2,000万個以上の家庭用妊娠検査キットが販売されていることである。各社は、HIV感染、糖尿病、C型肝炎、大腸がん、特にCOVID-19など、さまざまな病気を検出するための家庭用診断キットを発売し、提供する製品を多様化している。特にCOVID-19パンデミックの発生後、自己検査キットの需要が大幅に急増した。2021年、米国食品医薬品局（USFDA）は、COVID-19の診断に特化した100種類以上の家庭用自己検査キットの承認を承認した。

これらのキットの人気は、その高い信頼性、効率性、高い収率、血液、細胞、組織、血漿、唾液、微生物にまたがる広範な入力サンプルとの適合性に起因している。家庭用血液検査を含む家庭用検査キットの利用が増加し、多くの疾患適応症の診断に利用されるようになったことが、投資の大幅な増加につながった。米国の様々な政府機関は、過去5年間にこの分野に総額22億米ドル以上を投入している。

さらに、現在の市場環境は、主に妊娠の検出、グルコースレベルのモニタリング、排卵パターンの追跡のために開発されたキットによって、主に統合されている。感染症やセリアック病など、多様な治療領域にわたるポイント・オブ・ケア検査キットの普及は、当面、自己検査キットの開発者にチャンスをもたらすと予想される。

同時に、家庭での診断テストを遠隔医療と統合し、迅速なターンアラウンドタイムを促進する取り組みも進行中である。家庭用検査キット市場における絶え間ない技術革新は、ヘルスケアの展望に変革をもたらしている。業界各社がこの分野の進歩にたゆまぬ努力を続けていることから、来るべき予測期間において在宅検査キット市場は力強い成長が見込まれる。

レポート範囲
 調査中に得られた主要な洞察をまとめたエグゼクティブサマリー。家庭用自己検査キット市場の現状と中長期的な展開についてハイレベルな見解を提供しています。
 家庭用自己検査キットの簡単な概要であり、家庭用自己検査を実施する際の主なステップを強調している。さらに、利用可能な家庭用検査の種類と使用されるアッセイの種類を強調している。
 設立年、企業規模、本社所在地、検査手順の種類、検査形式の種類、検査目的、対象治療領域、装着性、分析対象物の調達方法、分析対象生物流体、処理時間、キット構成要素、規制当局の承認／認証、キットの再利用性、データ管理ツールの利用可能性、検出対象分析物、フォローアップ相談の必要性など、いくつかの関連パラメータに基づく、家庭用自己検査キット開発企業の現在の市場概況を詳細に紹介する。
 助成金授与年、授与額、支援期間、助成金申請、助成金授与の目的、助成金活動コード、NIH支出カテゴリー、関与する研究部門、NIH人気部門、受領者組織、受領者組織の地域分布など、複数の関連パラメータに基づき、2019年以前～2022年の期間に、家庭用自己検査キットに焦点を当てたプロジェクトのために様々な研究機関に授与された学術助成金に関する分析。
 家庭用自己検査キットメーカーの洞察に満ちた競争力分析を、企業の全体的な経験、製品ポートフォリオの強さ、ポートフォリオの多様性など、様々な関連パラメータに基づいて行う。
 この領域に従事する著名企業の詳細なプロフィール。各プロフィールには、企業の簡単な概要、財務情報に関する詳細（入手可能な場合）、製品ポートフォリオに関する情報、最近の開発、および情報に基づいた将来の展望が含まれています。
 Bowmanの戦略クロックフレームワークにより、企業が提供する家庭用自己検査キットの価格戦略を、競争上の地位とともに理解することができる。
 現在の株価、株式価値、企業価値、EBITDA、純利益、収益に基づき、上場企業の類似企業分析を活用した企業の本源的価値の推定。
 不妊・生殖医療、代謝性疾患、感染症、腫瘍性疾患など様々な治療領域にわたる、家庭用自己検査キットの年間需要に関する情報に基づく推定値。
 2035年までの家庭用自己検査キット市場の将来性を強調した洞察に満ちた市場予測分析。治療分野（不妊・生殖医療、代謝性疾患、感染症、腫瘍性疾患）、分析対象生物流体の種類（血液、尿、便、その他）、検査形式の種類（カセット、ストリップ、スティック、その他）、主要地域（北米、欧州、アジア太平洋、アフリカ、南米）に基づき区分しています。

主要市場企業
 エーコンラボラトリーズ
 アドバケアファーマUSA
 アペックスバイオテクノロジー
 アイセンス
 オークツリーヘルス
 タイドック・テクノロジー
 ビバチェック・ラボラトリーズ

ページTOPに戻る

1. PREFACE
1.1. Scope of the Report
1.2. Market Segmentation
1.3. Research Methodology
1.4. Key Questions Answered
1.5. Chapter Outlines
2. EXECUTIVE SUMMARY
2.1. Chapter Overview
3. INTRODUCTION
3.1. Chapter Overview
3.2. Introduction to At-Home Self-Testing
3.3. Types of At-home Tests
3.4. Types of At-home Test Assays
3.5. Advantages and Disadvantages Associated with At-home Self-testing Kits
3.6. Regulations Established for At-home Self-testing Kits
3.7. Future Perspective
4. MARKET OVERVIEW
4.1. Chapter Overview
4.2. At-home Self-testing Kits: List of Developers
4.2.1. Analysis by Year of Establishment
4.2.2. Analysis by Company Size
4.2.3. Analysis by Location of Headquarters
4.2.4. Analysis by Company Size and Location of Headquarters
4.3. At-home Self-testing Kits: Overall Market Landscape
4.3.1. Analysis by Type of Testing Procedure
4.3.2. Analysis by Type of Test Format
4.3.3. Analysis by Purpose of Testing
4.3.4. Analysis by Target Therapeutic Area
4.3.5. Analysis by Kit Components
4.3.6. Analysis by Kit Wearability
4.3.7. Analysis by Target Analyte Detected
4.3.8. Analysis by Type of Analyte Procurement Method
4.3.9. Analysis by Type of Biofluid Analyzed
4.3.10. Analysis by Processing Time
4.3.11. Analysis by Number of Regulatory Approvals
4.3.12. Analysis by Kit Reusability
4.3.13. Analysis by Availability of Data Management Tools
4.3.14. Analysis by Follow-up Consultation Requirement
5. GRANTS ANALYSIS
5.1. Chapter Overview
5.2. Scope and Methodology
5.3. At-home Self-testing Kits: Grant Analysis
5.3.1. Analysis by Year of Grant Award
5.3.2. Analysis by Amount Awarded
5.3.3. Analysis by Support Period
5.3.4. Analysis by Support Period and Funding Institute Center
5.3.5. Analysis by Type of Grant Application
5.3.6. Analysis by Purpose of Grant Award
5.3.7. Analysis by Activity Code
5.3.8. Analysis by NIH Spending Categories (Word Cloud Representation)
5.3.9. Analysis by Study Section Involved
5.3.10. Popular NIH Departments: Analysis by Number of Grants
5.3.11. Analysis by Type of Recipient Organization
5.3.12. Prominent Program Officers: Analysis by Number of Grants
5.3.13. Popular Recipient Organizations: Analysis by Number of Grants
5.3.14. Popular Recipient Organizations: Analysis by Amount Awarded
5.3.15. Analysis by Region of Recipient Organization
6. COMPANY COMPETITIVENESS ANALYSIS
6.1. Chapter Overview
6.2. Key Assumptions and Parameters
6.3. Methodology
6.4. At-home Self-testing Kit Developers: Company Competitiveness Analysis
6.4.1. At-home Self-testing Kits Developers Based in North America
6.4.2. At-home Self-testing Kits Developers Based in Europe
6.4.3. At-home Self-testing Kits Developers Based in Asia-Pacific and Rest of the World
6.4.4. At-home Self-testing Kits Developers: Competitive Benchmarking
7. COMPANY PROFILES
7.1. Chapter Overview
7.2. ACON Laboratories
7.2.1. Company Overview
7.2.2. Product Portfolio
7.2.3. Recent Developments and Future Outlook
7.3. AdvaCare Pharma USA
7.3.1. Company Overview
7.3.2. Product Portfolio
7.3.3. Recent Developments and Future Outlook
7.4. Apex Biotechnology
7.4.1. Company Overview
7.4.2. Product Portfolio
7.4.3. Recent Developments and Future Outlook
7.5. i-SENS
7.5.1. Company Overview
7.5.2. Financial Information
7.5.3. Product Portfolio
7.5.4. Recent Developments and Future Outlook
7.6. Oak Tree Health
7.6.1. Company Overview
7.6.2. Product Portfolio
7.6.3. Recent Developments and Future Outlook
7.7. TaiDoc Technology
7.7.1. Company Overview
7.7.2. Product Portfolio
7.7.3. Recent Developments and Future Outlook
7.8. VivaCheck Laboratories
7.8.1. Company Overview
7.8.2. Product Portfolio
7.8.3. Recent Developments and Future Outlook
8. BOWMAN CLOCK PRICING STRATEGY
8.1. Chapter Overview
8.2. Bowman Strategy Clock
8.2.1. Two Dimensions of Bowman Strategy Clock
8.2.2. Eight Positions on Bowman Strategy Clock
8.3. Roots Analysis Framework
8.3.1. Methodology
8.3.2. Theoretical Framework and Price Evaluation Hypothesis
8.3.3. Results and Interpretation
8.3.3.1. Product Price Evaluation Matrix: Information on Type of Diagnostic Assay
8.3.3.2. Product Price Evaluation Matrix: Information on Temperature
8.3.3.3. Product Price Evaluation Matrix: Information on Purpose of Testing
8.3.3.4. Product Price Evaluation Matrix: Information on Type of Target Analyte
8.3.3.5. Product Price Evaluation Matrix: Information on Type of Test Format
8.4. Concluding Remarks
9. COMPANY COMPARABLE ANALYSIS
9.1. Chapter Overview
9.2. Scope and Methodology
9.3. Operating Statistics for Comparable Companies
9.3.1. Operating Statistics: Abbott Laboratories
9.3.2. Operating Statistics: Roche
9.3.3. Operating Statistics: Johnson & Johnson
9.3.4. Operating Statistics: Median, 25th And 75th Percentile Multiple
9.4. Valuation Statistics for Comparable Companies
9.4.1. Valuation Statistics: Abbott Laboratories
9.4.2. Valuation Statistics: Roche
9.4.3. Valuation Statistics: Johnson & Johnson
9.4.4. Valuation Statistics: Median, 25th And 75th Percentile Multiple
9.5. Valuation Summary for Abbott Laboratories
9.5.1. Valuation Summary: Implied Share Price from Discount Cash Flow
9.5.2. Football Field Analysis: Abbott Laboratories
9.6. Valuation Summary for Roche
9.6.1. Valuation Summary: Implied Share Price from Discount Cash Flow
9.6.2. Football Field Analysis: Roche
9.7. Valuation Summary for Johnson & Johnson
9.7.1. Valuation Summary: Implied Share Price from Discount Cash Flow
9.7.2. Football Field Analysis: Johnson & Johnson
10. DEMAND ANALYSIS
10.1. Chapter Overview
10.2. Scope and Methodology
10.3. Global Demand for At-home Self-testing Kits
10.4. Demand for At-home Self-testing Kits: Analysis by Geography
10.5. Demand for At-home Self-testing Kits: Analysis by Therapeutic Area
10.5.1. Demand for At-home Self-testing Fertility and Reproductive Health Kits
10.5.1.1. Demand for At-home Self-testing Pregnancy Test Kits
10.5.1.1.1. Demand for At-home Self-testing Pregnancy Test Kits in North America
10.5.1.1.1.1. Demand for At-home Self-testing Pregnancy Test Kits in the US
10.5.1.1.1.2. Demand for At-home Self-testing Pregnancy Test Kits in Canada
10.5.1.1.1.3. Demand for At-home Self-testing Pregnancy Test Kits in Rest of North America
10.5.1.1.2. Demand for At-home Self-testing Pregnancy Test Kits in Europe
10.5.1.1.2.1. Demand for At-home Self-testing Pregnancy Test Kits in the UK
10.5.1.1.2.2. Demand for At-home Self-testing Pregnancy Test Kits in Germany
10.5.1.1.2.3. Demand for At-home Self-testing Pregnancy Test Kits in Spain
10.5.1.1.2.4. Demand for At-home Self-testing Pregnancy Test Kits in Italy
10.5.1.1.2.5. Demand for At-home Self-testing Pregnancy Test Kits in France
10.5.1.1.2.6. Demand for At-home Self-testing Pregnancy Test Kits in Rest of Europe
10.5.1.1.3. Demand for At-home Self-testing Pregnancy Test Kits in Asia-Pacific
10.5.1.1.3.1. Demand for At-home Self-testing Pregnancy Test Kits in India
10.5.1.1.3.2. Demand for At-home Self-testing Pregnancy Test Kits in China
10.5.1.1.3.3. Demand for At-home Self-testing Pregnancy Test Kits in Japan
10.5.1.1.3.4. Demand for At-home Self-testing Pregnancy Test Kits in South Korea
10.5.1.1.3.5. Demand for At-home Self-testing Pregnancy Test Kits in Indonesia
10.5.1.1.3.6. Demand for At-home Self-testing Pregnancy Test Kits in Rest of Asia-Pacific
10.5.1.1.4. Demand for At-home Self-testing Pregnancy Test Kits in Africa
10.5.1.1.4.1. Demand for At-home Self-testing Pregnancy Test Kits in Nigeria
10.5.1.1.4.2. Demand for At-home Self-testing Pregnancy Test Kits in Ethiopia
10.5.1.1.4.3. Demand for At-home Self-testing Pregnancy Test Kits in Egypt
10.5.1.1.4.4. Demand for At-home Self-testing Pregnancy Test Kits in Rest of Africa
10.5.1.1.5. Demand for At-home Self-testing Pregnancy Test Kits in South America
10.5.1.1.5.1. Demand for At-home Self-testing Pregnancy Test Kits in Argentina
10.5.1.1.5.2. Demand for At-home Self-testing Pregnancy Test Kits in Brazil
10.5.1.1.5.3. Demand for At-home Self-testing Pregnancy Test Kits in Rest of South America
10.5.1.2. Demand for At-home Self-testing Ovulation Test Kits
10.5.1.2.1. Demand for At-home Self-testing Ovulation Test Kits in North America
10.5.1.2.1.1. Demand for At-home Self-testing Ovulation Test Kits in the US
10.5.1.2.1.2. Demand for At-home Self-testing Ovulation Test Kits in Canada
10.5.1.2.1.3. Demand for At-home Self-testing Ovulation Test Kits in Rest of North America
10.5.1.2.2. Demand for At-home Self-testing Ovulation Test Kits in Europe
10.5.1.2.2.1. Demand for At-home Self-testing Ovulation Test Kits in the UK
10.5.1.2.2.2. Demand for At-home Self-testing Ovulation Test Kits in Germany
10.5.1.2.2.3. Demand for At-home Self-testing Ovulation Test Kits in Spain
10.5.1.2.2.4. Demand for At-home Self-testing Ovulation Test Kits in Italy
10.5.1.2.2.5. Demand for At-home Self-testing Ovulation Test Kits in France
10.5.1.2.2.6. Demand for At-home Self-testing Ovulation Test Kits in Rest of Europe
10.5.1.2.3. Demand for At-home Self-testing Ovulation Test Kits in Asia-Pacific
10.5.1.2.3.1. Demand for At-home Self-testing Ovulation Test Kits in India
10.5.1.2.3.2. Demand for At-home Self-testing Ovulation Test Kits in China
10.5.1.2.3.3. Demand for At-home Self-testing Ovulation Test Kits in Japan
10.5.1.2.3.4. Demand for At-home Self-testing Ovulation Test Kits in South Korea
10.5.1.2.3.5. Demand for At-home Self-testing Ovulation Test Kits in Indonesia
10.5.1.2.3.6. Demand for At-home Self-testing Ovulation Test Kits in Rest of Asia-Pacific
10.5.1.2.4. Demand for At-home Self-testing Ovulation Test Kits in Africa
10.5.1.2.4.1. Demand for At-home Self-testing Ovulation Test Kits in Nigeria
10.5.1.2.4.2. Demand for At-home Self-testing Ovulation Test Kits in Ethiopia
10.5.1.2.4.3. Demand for At-home Self-testing Ovulation Test Kits in Egypt
10.5.1.2.4.4. Demand for At-home Self-testing Ovulation Test Kits in Rest of Africa
10.5.1.2.5. Demand for At-home Self-testing Ovulation Test Kits in South America
10.5.1.2.5.1. Demand for At-home Self-testing Ovulation Test Kits in Argentina
10.5.1.2.5.2. Demand for At-home Self-testing Ovulation Test Kits in Brazil
10.5.1.2.5.3. Demand for At-home Self-testing Ovulation Test Kits in Rest of South America
10.5.2. Demand for At-home Self-testing Infectious Diseases Kits
10.5.2.1. Demand for At-home Self-testing HIV Test Kits
10.5.2.1.1. Demand for At-home Self-testing HIV Test Kits in North America
10.5.2.1.1.1. Demand for At-home Self-testing HIV Test Kits in the US
10.5.2.1.1.2. Demand for At-home Self-testing HIV Test Kits in Canada
10.5.2.1.1.3. Demand for At-home Self-testing HIV Test Kits in Rest of North America
10.5.2.1.2. Demand for At-home Self-testing HIV Test Kits in Europe
10.5.2.1.2.1. Demand for At-home Self-testing HIV Test Kits in the UK
10.5.2.1.2.2. Demand for At-home Self-testing HIV Test Kits in Germany
10.5.2.1.2.3. Demand for At-home Self-testing HIV Test Kits in Spain
10.5.2.1.2.4. Demand for At-home Self-testing HIV Test Kits in Italy
10.5.2.1.2.5. Demand for At-home Self-testing HIV Test Kits in France
10.5.2.1.2.6. Demand for At-home Self-testing HIV Test Kits in Rest of Europe
10.5.2.1.3. Demand for At-home Self-testing HIV Test Kits in Asia-Pacific
10.5.2.1.3.1. Demand for At-home Self-testing HIV Test Kits in India
10.5.2.1.3.2. Demand for At-home Self-testing HIV Test Kits in China
10.5.2.1.3.3. Demand for At-home Self-testing HIV Test Kits in Japan
10.5.2.1.3.4. Demand for At-home Self-testing HIV Test Kits in South Korea
10.5.2.1.3.5. Demand for At-home Self-testing HIV Test Kits in Indonesia
10.5.2.1.3.6. Demand for At-home Self-testing HIV Test Kits in Rest of Asia-Pacific
10.5.2.1.4. Demand for At-home Self-testing HIV Test Kits in Africa
10.5.2.1.4.1. Demand for At-home Self-testing HIV Test Kits in Nigeria
10.5.2.1.4.2. Demand for At-home Self-testing HIV Test Kits in Ethiopia
10.5.2.1.4.3. Demand for At-home Self-testing HIV Test Kits in Egypt
10.5.2.1.4.4. Demand for At-home Self-testing HIV Test Kits in Rest of Africa
10.5.2.1.5. Demand for At-home Self-testing HIV Test Kits in South America
10.5.2.1.5.1. Demand for At-home Self-testing HIV Test Kits in Argentina
10.5.2.1.5.2. Demand for At-home Self-testing HIV Test Kits in Brazil
10.5.2.1.5.3. Demand for At-home Self-testing HIV Test Kits in Rest of South America
10.5.3. Demand for At-home Self-testing Metabolic Disorders Kits
10.5.3.1. Demand for At-home Self-testing Diabetes Test Kits
10.5.3.1.1. Demand for At-home Self-testing Diabetes Test Kits in North America
10.5.3.1.1.1. Demand for At-home Self-testing Diabetes Test Kits in the US
10.5.3.1.1.2. Demand for At-home Self-testing Diabetes Test Kits in Canada
10.5.3.1.1.3. Demand for At-home Self-testing Diabetes Test Kits in Rest of North America
10.5.3.1.2. Demand for At-home Self-testing Diabetes Test Kits in Europe
10.5.3.1.2.1. Demand for At-home Self-testing Diabetes Test Kits in the UK
10.5.3.1.2.2. Demand for At-home Self-testing Diabetes Test Kits in Germany
10.5.3.1.2.3. Demand for At-home Self-testing Diabetes Test Kits in Spain
10.5.3.1.2.4. Demand for At-home Self-testing Diabetes Test Kits in Italy
10.5.3.1.2.5. Demand for At-home Self-testing Diabetes Test Kits in France
10.5.3.1.2.6. Demand for At-home Self-testing Diabetes Test Kits in Rest of Europe
10.5.3.1.3. Demand for At-home Self-testing Diabetes Test Kits in Asia-Pacific
10.5.3.1.3.1. Demand for At-home Self-testing Diabetes Test Kits in India
10.5.3.1.3.2. Demand for At-home Self-testing Diabetes Test Kits in China
10.5.3.1.3.3. Demand for At-home Self-testing Diabetes Test Kits in Japan
10.5.3.1.3.4. Demand for At-home Self-testing Diabetes Test Kits in South Korea
10.5.3.1.3.5. Demand for At-home Self-testing Diabetes Test Kits in Indonesia
10.5.3.1.3.6. Demand for At-home Self-testing Diabetes Test Kits in Rest of Asia-Pacific
10.5.3.1.4. Demand for At-home Self-testing Diabetes Test Kits in Africa
10.5.3.1.4.1. Demand for At-home Self-testing Diabetes Test Kits in Nigeria
10.5.3.1.4.2. Demand for At-home Self-testing Diabetes Test Kits in Ethiopia
10.5.3.1.4.3. Demand for At-home Self-testing Diabetes Test Kits in Egypt
10.5.3.1.4.4. Demand for At-home Self-testing Diabetes Test Kits in Rest of Africa
10.5.3.1.5. Demand for At-home Self-testing Diabetes Test Kits in South America
10.5.3.1.5.1. Demand for At-home Self-testing Diabetes Test Kits in Argentina
10.5.3.1.5.2. Demand for At-home Self-testing Diabetes Test Kits in Brazil
10.5.3.1.5.3. Demand for At-home Self-testing Diabetes Test Kits in Rest of South America
10.5.4. Demand for At-home Self-testing Oncological Disorders Kits
10.5.4.1. Demand for At-home Self-testing Colon Cancer Test Kits
10.5.4.1.1. Demand for At-home Self-testing Colon Cancer Test Kits in North America
10.5.4.1.1.1. Demand for At-home Self-testing Colon Cancer Test Kits in the US
10.5.4.1.1.2. Demand for At-home Self-testing Colon Cancer Test Kits in Canada
10.5.4.1.1.3. Demand for At-home Self-testing Colon Cancer Test Kits in Rest of North America
10.5.4.1.2. Demand for At-home Self-testing Colon Cancer Test Kits in Europe
10.5.4.1.2.1. Demand for At-home Self-testing Colon Cancer Test Kits in the UK
10.5.4.1.2.2. Demand for At-home Self-testing Colon Cancer Test Kits in Germany
10.5.4.1.2.3. Demand for At-home Self-testing Colon Cancer Test Kits in Spain
10.5.4.1.2.4. Demand for At-home Self-testing Colon Cancer Test Kits in Italy
10.5.4.1.2.5. Demand for At-home Self-testing Colon Cancer Test Kits in France
10.5.4.1.2.6. Demand for At-home Self-testing Colon Cancer Test Kits in Rest of Europe
10.5.4.1.3. Demand for At-home Self-testing Colon Cancer Test Kits in Asia-Pacific
10.5.4.1.3.1. Demand for At-home Self-testing Colon Cancer Test Kits in India
10.5.4.1.3.2. Demand for At-home Self-testing Colon Cancer Test Kits in China
10.5.4.1.3.3. Demand for At-home Self-testing Colon Cancer Test Kits in Japan
10.5.4.1.3.4. Demand for At-home Self-testing Colon Cancer Test Kits in South Korea
10.5.4.1.3.5. Demand for At-home Self-testing Colon Cancer Test Kits in Indonesia
10.5.4.1.3.6. Demand for At-home Self-testing Colon Cancer Test Kits in Rest of Asia-Pacific
10.5.4.1.4. Demand for At-home Self-testing Colon Cancer Test Kits in Africa
10.5.4.1.4.1. Demand for At-home Self-testing Colon Cancer Test Kits in Nigeria
10.5.4.1.4.2. Demand for At-home Self-testing Colon Cancer Test Kits in Ethiopia
10.5.4.1.4.3. Demand for At-home Self-testing Colon Cancer Test Kits in Egypt
10.5.4.1.4.4. Demand for At-home Self-testing Colon Cancer Test Kits in Rest of Africa
10.5.4.1.5. Demand for At-home Self-testing Colon Cancer Test Kits in South America
10.5.4.1.5.1. Demand for At-home Self-testing Colon Cancer Test Kits in Argentina
10.5.4.1.5.2. Demand for At-home Self-testing Colon Cancer Test Kits in Brazil
10.5.4.1.5.3. Demand for At-home Self-testing Colon Cancer Test Kits in Rest of South America
10.6. Concluding Remarks
11. MARKET FORECAST AND OPPUTUNITY ANALYSIS
11.1. Chapter Overview
11.2. Scope and Methodology
11.3. Global At-home Self-testing Kits Market, 2022-2035
11.4. At-home Self-testing Kits Market: Analysis by Geography, 2022 and 2035
11.5. At-home Self-testing Kits Market: Analysis by Therapeutic Area, 2022-2035
11.5.1. At-home Self-testing Kits Market for Fertility and Reproductive Health, 2022-2035
11.5.1.1. At-home Self-testing Kits Market for Pregnancy Detection, 2022-2035
11.5.1.1.1. At-home Self-testing Kits Market for Pregnancy Detection in North America, 2022-2035
11.5.1.1.1.1. At-home Self-testing Kits Market for Pregnancy Detection in the US, 2022-2035
11.5.1.1.1.2. At-home Self-testing Kits Market for Pregnancy Detection in Canada, 2022-2035
11.5.1.1.1.3. At-home Self-testing Kits Market for Pregnancy Detection in Rest of North America, 2022-2035
11.5.1.1.2. At-home Self-testing Kits Market for Pregnancy Detection in Europe, 2022-2035
11.5.1.1.2.1. At-home Self-testing Kits Market for Pregnancy Detection in the UK, 2022-2035
11.5.1.1.2.2. At-home Self-testing Kits Market for Pregnancy Detection in Germany, 2022-2035
11.5.1.1.2.3. At-home Self-testing Kits Market for Pregnancy Detection in Spain, 2022-2035
11.5.1.1.2.4. At-home Self-testing Kits Market for Pregnancy Detection in Italy, 2022-2035
11.5.1.1.2.5. At-home Self-testing Kits Market for Pregnancy Detection in France, 2022-2035
11.5.1.1.2.6. At-home Self-testing Kits Market for Pregnancy Detection in Rest of Europe, 2022-2035
11.5.1.1.3. At-home Self-testing Kits Market for Pregnancy Detection in Asia-Pacific, 2022-2035
11.5.1.1.3.1. At-home Self-testing Kits Market for Pregnancy Detection in India, 2022-2035
11.5.1.1.3.2. At-home Self-testing Kits Market for Pregnancy Detection in China, 2022-2035
11.5.1.1.3.3. At-home Self-testing Kits Market for Pregnancy Detection in Japan, 2022-2035
11.5.1.1.3.4. At-home Self-testing Kits Market for Pregnancy Detection in South Korea, 2022-2035
11.5.1.1.3.5. At-home Self-testing Kits Market for Pregnancy Detection in Indonesia, 2022-2035
11.5.1.1.3.6. At-home Self-testing Kits Market for Pregnancy Detection in Rest of Asia-Pacific, 2022-2035
11.5.1.1.4. At-home Self-testing Kits Market for Pregnancy Detection in Africa, 2022-2035
11.5.1.1.4.1. At-home Self-testing Kits Market for Pregnancy Detection in Nigeria, 2022-2035
11.5.1.1.4.2. At-home Self-testing Kits Market for Pregnancy Detection in Ethiopia, 2022-2035
11.5.1.1.4.3. At-home Self-testing Kits Market for Pregnancy Detection in Egypt, 2022-2035
11.5.1.1.4.4. At-home Self-testing Kits Market for Pregnancy Detection in Rest of Africa, 2022-2035
11.5.1.1.5. At-home Self-testing Kits Market for Pregnancy Detection in South America, 2022-2035
11.5.1.1.5.1. At-home Self-testing Kits Market for Pregnancy Detection in Argentina, 2022-2035
11.5.1.1.5.2. At-home Self-testing Kits Market for Pregnancy Detection in Brazil, 2022-2035
11.5.1.1.5.3. At-home Self-testing Kits Market for Pregnancy Detection in Rest of South America, 2022-2035
11.5.1.2. At-home Self-testing Kits Market for Ovulation Monitoring, 2022-2035
11.5.1.2.1. At-home Self-testing Kits Market for Ovulation Monitoring in North America, 2022-2035
11.5.1.2.1.1. At-home Self-testing Kits Market for Ovulation Monitoring in the US, 2022-2035
11.5.1.2.1.2. At-home Self-testing Kits Market for Ovulation Monitoring in Canada, 2022-2035
11.5.1.2.1.3. At-home Self-testing Kits Market for Ovulation Monitoring in Rest of North America, 2022-2035
11.5.1.2.2. At-home Self-testing Kits Market for Ovulation Monitoring in Europe, 2022-2035
11.5.1.2.2.1. At-home Self-testing Kits Market for Ovulation Monitoring in the UK, 2022-2035
11.5.1.2.2.2. At-home Self-testing Kits Market for Ovulation Monitoring in Germany, 2022-2035
11.5.1.2.2.3. At-home Self-testing Kits Market for Ovulation Monitoring in Spain, 2022-2035
11.5.1.2.2.4. At-home Self-testing Kits Market for Ovulation Monitoring in Italy, 2022-2035
11.5.1.2.2.5. At-home Self-testing Kits Market for Ovulation Monitoring in France, 2022-2035
11.5.1.2.2.6. At-home Self-testing Kits Market for Ovulation Monitoring in Rest of Europe, 2022-2035
11.5.1.2.3. At-home Self-testing Kits Market for Ovulation Monitoring in Asia-Pacific, 2022-2035
11.5.1.2.3.1. At-home Self-testing Kits Market for Ovulation Monitoring in India, 2022-2035
11.5.1.2.3.2. At-home Self-testing Kits Market for Ovulation Monitoring in China, 2022-2035
11.5.1.2.3.3. At-home Self-testing Kits Market for Ovulation Monitoring in Japan, 2022-2035
11.5.1.2.3.4. At-home Self-testing Kits Market for Ovulation Monitoring in South Korea, 2022-2035
11.5.1.2.3.5. At-home Self-testing Kits Market for Ovulation Monitoring in Indonesia, 2022-2035
11.5.1.2.3.6. At-home Self-testing Kits Market for Ovulation Monitoring in Rest of Asia-Pacific, 2022-2035
11.5.1.2.4. At-home Self-testing Kits Market for Ovulation Monitoring in Africa, 2022-2035
11.5.1.2.4.1. At-home Self-testing Kits Market for Ovulation Monitoring in Nigeria, 2022-2035
11.5.1.2.4.2. At-home Self-testing Kits Market for Ovulation Monitoring in Ethiopia, 2022-2035
11.5.1.2.4.3. At-home Self-testing Kits Market for Ovulation Monitoring in Egypt, 2022-2035
11.5.1.2.4.4. At-home Self-testing Kits Market for Ovulation Monitoring in Rest of Africa, 2022-2035
11.5.1.2.5. At-home Self-testing Kits Market for Ovulation Monitoring in South America, 2022-2035
11.5.1.2.5.1. At-home Self-testing Kits Market for Ovulation Monitoring in Argentina, 2022-2035
11.5.1.2.5.2. At-home Self-testing Kits Market for Ovulation Monitoring in Brazil, 2022-2035
11.5.1.2.5.3. At-home Self-testing Kits Market for Ovulation Monitoring in Rest of South America, 2022-2035
11.5.2. At-home Self-testing Kits Market for Infectious Diseases, 2022-2035
11.5.2.1. At-home Self-testing Kits Market for HIV Detection, 2022-2035
11.5.2.1.1. At-home Self-testing Kits Market for HIV Detection in North America, 2022-2035
11.5.2.1.1.1. At-home Self-testing Kits Market for HIV Detection in the US, 2022-2035
11.5.2.1.1.2. At-home Self-testing Kits Market for HIV Detection in Canada, 2022-2035
11.5.2.1.1.3. At-home Self-testing Kits Market for HIV Detection in Rest of North America, 2022-2035
11.5.2.1.2. At-home Self-testing Kits Market for HIV Detection in Europe, 2022-2035
11.5.2.1.2.1. At-home Self-testing Kits Market for HIV Detection in the UK, 2022-2035
11.5.2.1.2.2. At-home Self-testing Kits Market for HIV Detection in Germany, 2022-2035
11.5.2.1.2.3. At-home Self-testing Kits Market for HIV Detection in Spain, 2022-2035
11.5.2.1.2.4. At-home Self-testing Kits Market for HIV Detection in Italy, 2022-2035
11.5.2.1.2.5. At-home Self-testing Kits Market for HIV Detection in France, 2022-2035
11.5.2.1.2.6. At-home Self-testing Kits Market for HIV Detection in Rest of Europe, 2022-2035
11.5.2.1.3. At-home Self-testing Kits Market for HIV Detection in Asia-Pacific, 2022-2035
11.5.2.1.3.1. At-home Self-testing Kits Market for HIV Detection in India, 2022-2035
11.5.2.1.3.2. At-home Self-testing Kits Market for HIV Detection in China, 2022-2035
11.5.2.1.3.3. At-home Self-testing Kits Market for HIV Detection in Japan, 2022-2035
11.5.2.1.3.4. At-home Self-testing Kits Market for HIV Detection in South Korea, 2022-2035
11.5.2.1.3.5. At-home Self-testing Kits Market for HIV Detection in Indonesia, 2022-2035
11.5.2.1.3.6. At-home Self-testing Kits Market for HIV Detection in Rest of Asia-Pacific, 2022-2035
11.5.2.1.4. At-home Self-testing Kits Market for HIV Detection in Africa, 2022-2035
11.5.2.1.4.1. At-home Self-testing Kits Market for HIV Detection in Nigeria, 2022-2035
11.5.2.1.4.2. At-home Self-testing Kits Market for HIV Detection in Ethiopia, 2022-2035
11.5.2.1.4.3. At-home Self-testing Kits Market for HIV Detection in Egypt, 2022-2035
11.5.2.1.4.4. At-home Self-testing Kits Market for HIV Detection in Rest of Africa, 2022-2035
11.5.2.1.5. At-home Self-testing Kits Market for HIV Detection in South America, 2022-2035
11.5.2.1.5.1. At-home Self-testing Kits Market for HIV Detection in Argentina, 2022-2035
11.5.2.1.5.2. At-home Self-testing Kits Market for HIV Detection in Brazil, 2022-2035
11.5.2.1.5.3. At-home Self-testing Kits Market for HIV Detection in Rest of South America, 2022-2035
11.5.3. At-home Self-testing Kits Market for Metabolic Disorders, 2022-2035
11.5.3.1. At-home Self-testing Kits Market for Diabetes Monitoring, 2022-2035
11.5.3.1.1. At-home Self-testing Kits Market for Diabetes Monitoring in North America, 2022-2035
11.5.3.1.1.1. At-home Self-testing Kits Market for Diabetes Monitoring in the US, 2022-2035
11.5.3.1.1.2. At-home Self-testing Kits Market for Diabetes Monitoring in Canada, 2022-2035
11.5.3.1.1.3. At-home Self-testing Kits Market for Diabetes Monitoring in Rest of North America, 2022-2035
11.5.3.1.2. At-home Self-testing Kits Market for Diabetes Monitoring in Europe, 2022-2035
11.5.3.1.2.1. At-home Self-testing Kits Market for Diabetes Monitoring in the UK, 2022-2035
11.5.3.1.2.2. At-home Self-testing Kits Market for Diabetes Monitoring in Germany, 2022-2035
11.5.3.1.2.3. At-home Self-testing Kits Market for Diabetes Monitoring in Spain, 2022-2035
11.5.3.1.2.4. At-home Self-testing Kits Market for Diabetes Monitoring in Italy, 2022-2035
11.5.3.1.2.5. At-home Self-testing Kits Market for Diabetes Monitoring in France, 2022-2035
11.5.3.1.2.6. At-home Self-testing Kits Market for Diabetes Monitoring in Rest of Europe, 2022-2035
11.5.3.1.3. At-home Self-testing Kits Market for Diabetes Monitoring in Asia-Pacific, 2022-2035
11.5.3.1.3.1. At-home Self-testing Kits Market for Diabetes Monitoring in India, 2022-2035
11.5.3.1.3.2. At-home Self-testing Kits Market for Diabetes Monitoring in China, 2022-2035
11.5.3.1.3.3. At-home Self-testing Kits Market for Diabetes Monitoring in Japan, 2022-2035
11.5.3.1.3.4. At-home Self-testing Kits Market for Diabetes Monitoring in South Korea, 2022- 2035
11.5.3.1.3.5. At-home Self-testing Kits Market for Diabetes Monitoring in Indonesia, 2022-2035
11.5.3.1.3.6. At-home Self-testing Kits Market for Diabetes Monitoring in Rest of Asia-Pacific, 2022-2035
11.5.3.1.4. At-home Self-testing Kits Market for Diabetes Monitoring in Africa, 2022-2035
11.5.3.1.4.1. At-home Self-testing Kits Market for Diabetes Monitoring in Nigeria, 2022-2035
11.5.3.1.4.2. At-home Self-testing Kits Market for Diabetes Monitoring in Ethiopia, 2022-2035
11.5.3.1.4.3. At-home Self-testing Kits Market for Diabetes Monitoring in Egypt, 2022-2035
11.5.3.1.4.4. At-home Self-testing Kits Market for Diabetes Monitoring in Rest of Africa, 2022-2035
11.5.3.1.5. At-home Self-testing Kits Market for Diabetes Monitoring in South America, 2022-2035
11.5.3.1.5.1. At-home Self-testing Kits Market for Diabetes Monitoring in Argentina, 2022-2035
11.5.3.1.5.2. At-home Self-testing Kits Market for Diabetes Monitoring in Brazil, 2022-2035
11.5.3.1.5.3. At-home Self-testing Kits Market for Diabetes Monitoring in Rest of South America, 2022-2035
11.5.4. At-home Self-testing Kits Market for Oncological Disorders, 2022-2035
11.5.4.1. At-home Self-testing Kits Market for Colon Cancer Detection, 2022-2035
11.5.4.1.1. At-home Self-testing Kits Market for Colon Cancer Detection in North America, 2022-2035
11.5.4.1.1.1. At-home Self-testing Kits Market for Colon Cancer Detection in the US, 2022-2035
11.5.4.1.1.2. At-home Self-testing Kits Market for Colon Cancer Detection in Canada, 2022-2035
11.5.4.1.1.3. At-home Self-testing Kits Market for Colon Cancer Detection in Rest of North America, 2022-2035
11.5.4.1.2. At-home Self-testing Kits Market for Colon Cancer Detection in Europe, 2022-2035
11.5.4.1.2.1. At-home Self-testing Kits Market for Colon Cancer Detection in the UK, 2022-2035
11.5.4.1.2.2. At-home Self-testing Kits Market for Colon Cancer Detection in Germany, 2022-2035
11.5.4.1.2.3. At-home Self-testing Kits Market for Colon Cancer Detection in Spain, 2022-2035
11.5.4.1.2.4. At-home Self-testing Kits Market for Colon Cancer Detection in Italy, 2022-2035
11.5.4.1.2.5. At-home Self-testing Kits Market for Colon Cancer Detection in France, 2022-2035
11.5.4.1.2.6. At-home Self-testing Kits Market for Colon Cancer Detection in Rest of Europe, 2022-2035
11.5.4.1.3. At-home Self-testing Kits Market for Colon Cancer Detection in Asia-Pacific, 2022-2035
11.5.4.1.3.1. At-home Self-testing Kits Market for Colon Cancer Detection in India, 2022-2035
11.5.4.1.3.2. At-home Self-testing Kits Market for Colon Cancer Detection in China, 2022-2035
11.5.4.1.3.3. At-home Self-testing Kits Market for Colon Cancer Detection in Japan, 2022-2035
11.5.4.1.3.4. At-home Self-testing Kits Market for Colon Cancer Detection in South Korea, 2022-2035
11.5.4.1.3.5. At-home Self-testing Kits Market for Colon Cancer Detection in Indonesia, 2022-2035
11.5.4.1.3.6. At-home Self-testing Kits Market for Colon Cancer Detection in Rest of Asia-Pacific, 2022-2035
11.5.4.1.4. At-home Self-testing Kits Market for Colon Cancer Detection in Africa, 2022-2035
11.5.4.1.4.1. At-home Self-testing Kits Market for Colon Cancer Detection in Nigeria, 2022-2035
11.5.4.1.4.2. At-home Self-testing Kits Market for Colon Cancer Detection in Ethiopia, 2022-2035
11.5.4.1.4.3. At-home Self-testing Kits Market for Colon Cancer Detection in Egypt, 2022-2035
11.5.4.1.4.4. At-home Self-testing Kits Market for Colon Cancer Detection in Rest of Africa, 2022-2035
11.5.4.1.5. At-home Self-testing Kits Market for Colon Cancer Detection in South America, 2022-2035
11.5.4.1.5.1. At-home Self-testing Kits Market for Colon Cancer Detection in Argentina, 2022-2035
11.5.4.1.5.2. At-home Self-testing Kits Market for Colon Cancer Detection in Brazil, 2022-2035
11.5.4.1.5.3. At-home Self-testing Kits Market for Colon Cancer Detection in Rest of South America
11.6. At-home Self-testing Kits Market: Analysis by Type of Test Format, 2022-2035
11.6.1. At-home Self-testing Kits Market for Stick based Tests, 2022-2035
11.6.2. At-home Self-testing Kits Market for Strip based Tests, 2022-2035
11.6.3. At-home Self-testing Kits Market for Cassette based Tests, 2022-2035
11.6.4. At-home Self-testing Kits Market for Other Formats, 2022-2035
11.7. At-home Self-testing Kits Market: Analysis by Type of Biofluid Analyzed, 2022-2035
11.7.1. At-home Self-testing Kits Market for Urine based Tests, 2022-2035
11.7.2. At-home Self-testing Kits Market for Blood based Tests, 2022-2035
11.7.3. At-home Self-testing Kits Market for Stool based Tests, 2022-2035
12. ATTRACTIVENESS COMPETETIVENESS MATRIX
12.1. Chapter Overview
12.2. AC Matrix: An Overview
12.2.1. Strong Business Segments
12.2.2. Average Business Segments
12.2.3. Weak Business Segments
12.3. Analytical Methodology
12.4. AC Matrix: Overall At-home Self-testing Kits Market Scenario
12.4.1. AC Matrix: Overall At-home Self-testing Kits Market Scenario for Target Therapeutic Area
12.4.2. AC Matrix: Overall At-home Self-testing Kits Market Scenario for Regions
13. CONCLUDING REMARKS
14. INTERVIEW TRANSCRIPTS
14.1. Chapter Overview
14.2. Apex Biotechnology
14.2.1. Company Snapshot
14.2.2. Interview Transcript: Ben Shen (Vice President, Sales, and Marketing)
14.3. Mankind Pharma
14.3.1. Company Snapshot
14.3.2. Interview Transcript: Joy Chatterjee (Associate Vice President)
15. APPENDIX I: TABULATED DATA
16. APPENDIX II: LIST OF COMPANIES AND ORGANIZATIONS

ページTOPに戻る

Table of Contents

Summary

The at home testing market is estimated to reach USD 14.8 billion in 2022 and is anticipated to grow at a CAGR of 6% during the forecast period 2022-2035.

Since the advent of the initial over-the-counter test kits in the early phases of 1976, there has been a notable upsurge in efforts aimed at developing such products. A significant indicator of market vitality is the annual sale of over 20 million at-home pregnancy test kits in the United States. Companies have diversified their offerings by introducing at-home diagnostic kits for detecting various diseases such as HIV infection, diabetes, Hepatitis C, colon cancer, and notably, COVID-19. Particularly following the onset of the COVID-19 pandemic, there has been a substantial surge in the demand for self-testing kits. In 2021, the USFDA authorized the approval of more than 100 at-home self-testing kits designed specifically for diagnosing COVID-19.

The popularity of these kits can be attributed to their heightened reliability, efficiency, high yield, and compatibility with a wide spectrum of input samples, spanning blood, cells, tissues, plasma, saliva, and microbes. The increased utilization of at-home testing kits, including at-home blood tests, in diagnosing numerous disease indications has led to significant increases in investments. Various government institutions in the US have collectively infused over USD 2.2 billion into this sector over the past five years.

Furthermore, the current market landscape is predominantly consolidated, mainly driven by kits developed for detecting pregnancies, monitoring glucose levels, and tracking ovulation patterns. The proliferation of point-of-care test kits across diverse therapeutic domains, including infectious diseases and celiac diseases, is expected to create opportunities for developers of self-testing kits in the foreseeable future.

Concurrently, efforts are underway to integrate at-home diagnostic tests with telemedicine, aiming to facilitate rapid turnaround times. The continuous innovation within the at-home testing kits market is poised to bring about a transformative shift in the healthcare landscape. With industry players persistently endeavoring to advance this field, robust growth is anticipated in the at-home testing kits market in the forthcoming forecast period.

Report Coverage
 An executive summary of the key insights captured during the research. It offers a high-level view of the current state of at-home self-testing kits market and its likely evolution in the mid to long term.
 A brief overview of at-home self-testing kits, highlighting the key steps involved while performing at-home self-tests. Further, it highlights the types of at-home tests available, and the types of assays used.
 A detailed overview of the current market landscape of at-home self-testing kit developers, based on several relevant parameters, such as year of establishment, company size, location of headquarters, type of testing procedure, type of test format, purpose of testing, target therapeutic area, wearability, analyte procurement method, biofluid analyzed, processing time, kit components, regulatory approvals / certifications, kit reusability, availability of data management tools, target analyte detected, and follow-up consultation requirement.
 An analysis on academic grants that have been awarded to various research institutes for projects focused on at-home self-testing kits, during the period, pre-2019-2022, based on several relevant parameters, such as year of grant award, amount awarded, support period, grant application, purpose of grant award, grant activity code, NIH spending category, study section involved, popular NIH departments, recipient organization, regional distribution of recipient organization.
 An insightful competitiveness analysis of at-home self-testing kit manufacturers based on various relevant parameters, such as overall experience of the company, product portfolio strength and portfolio diversity.
 Elaborate profiles of prominent players engaged in this domain. Each profile includes a brief overview of the company, details related to its financial information (if available), information on product portfolio, recent developments, and an informed future outlook.
 Bowman’s strategy clock framework to understand the pricing strategy of the at-home self-test kits offered by a company, along with its competitive position.
 An estimate of company’s intrinsic value by utilizing comparable company analysis of publicly listed companies based on their current share price, equity value, enterprise value, EBITDA, net income, and revenue.
 An informed estimate of the annual demand for at-home self-testing kits, across various therapeutic areas such as, fertility and reproductive health, metabolic disorders, infectious diseases, and oncological disorders.
 An insightful market forecast analysis, highlighting the future potential of at-home self-testing kits market till 2035. We have segmented on the basis of therapeutic area (fertility and reproductive health, metabolic disorders, infectious diseases, and oncological disorders), type of biofluid analyzed (blood, urine, stool, and others), type of test format (cassette, strip, stick, and others), key geographical regions (North America, Europe, Asia-Pacific, Africa, and South America).

Key Market Companies
 ACON Laboratories
 AdvaCare Pharma USA
 Apex Biotechnology
 i-SENS
 Oak Tree Health
 TaiDoc Technology
 VivaCheck Laboratories

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野の最新刊レポート

本レポートと同分野の最新刊レポートはありません。

Roots Analysis社の分野での最新刊レポート

最新刊レポートはありません。

本レポートと同じKEY WORD（）の最新刊レポート

本レポートと同じKEY WORDの最新刊レポートはありません。

よくあるご質問

Roots Analysis社はどのような調査会社ですか?

Roots Analysisは2013年設立の医薬品・医療機器が専門の調査会社です。医薬品の製造委託や創薬のデジタル化など、最新の医薬業界の分析を行っています。もっと見る

調査レポートの納品までの日数はどの程度ですか?

在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。

注文の手続きはどのようになっていますか?

1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。

お支払方法の方法はどのようになっていますか?

納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。

データリソース社はどのような会社ですか?

当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。

サマリー

目次

Summary

Table of Contents

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

本レポートと同分野の最新刊レポート

Roots Analysis社の分野での最新刊レポート

本レポートと同じKEY WORD（）の最新刊レポート

よくあるご質問

Roots Analysis社はどのような調査会社ですか?

調査レポートの納品までの日数はどの程度ですか?

注文の手続きはどのようになっていますか?

お支払方法の方法はどのようになっていますか?

データリソース社はどのような会社ですか?